Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

With New Center, DCI Tackles Brain Metastasis Head-On

During the summer of 2016 Dave and Lisa VanTress retired from their jobs in Syracuse, New York, and headed south to the sunny shores of South Carolina, where they could be close to family and indulge their passion for fishing. They bought a townhouse in Little River, a five-minute drive to the...

Ashley Awarded V Foundation Grant for Poliovirus Research

The V Foundation for Cancer Research has awarded David Ashley, MBBS, FRACP, PhD, a three-year $600,000 grant for his proposed research project “Poliovirus-Instigated APC Responses Against BRaf (V600E) for Pedatric Brain Tumor Immunotherapy.” In July 2017 Ashley was named director of Pediatric Neuro...

Heitman Receives ASCI Award

Joseph Heitman, MD, PhD , is the recipient of the 2018 American Society for Clinical Investigation’s (ASCI) Stanley J. Korsmeyer Award for his key contributions to the understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance; and his discovery of TOR...

Chocolatier Turned Oncology Research Coordinator Sweetens The Day For Patients At Caring House

Most people indulge in some sort of hobby — dipping into this and dipping into that. However, for Diane Pinder, a clinical research coordinator, her love of chocolate is more than just an indulgence — it is another way she’s found to reach out and care for others. Pinder, one-time chocolatier, and...

Sample Named Assistant Vice President, Clinical Programs

Laura Sample, MHA, has been named assistant vice president for Duke Cancer Institute’s clinical programs. In her new role, she will serve as the senior leader for the administrative functions of the disease-based programs, providing oversight for the development of strategic business plans focused...

Pancreatic Cancer: Facing a Formidable Foe

In February 2016, Tara Wilkes left her job as a decorator and furniture sales associate, locked the door of her second home on Lake Waccamaw and moved back inland to the family home in Rockingham, North Carolina. “I just couldn’t do my job,” said Wilkes, a petite and active 56-year-old grandmother...

In Canines, A Novel Approach To An Old Drug

Cancer is the leading cause of death in dogs, with one in four developing the disease in his or her lifetime. For humans, it’s one in three. America’s 83 million pet dogs share our environment, have similar genomes and develop spontaneous tumors much like we do. Canine tumors have similar imaging...

IBC Consortium To Host First-Ever Annual Meeting (2.28.18)

In partnership with the Duke School of Medicine, Duke Cancer Institute, Duke Department of Surgery, and the IBC Network Foundation , the Duke Consortium for Inflammatory Breast Cancer (IBC) will host its first-ever Annual Meeting, “Engaging Our Community in IBC Research and Awareness,” on Wednesday...

Researchers Identify New Way to Unmask Melanoma Cells to the Immune System

Melanomas have an especially lethal ability to turn off the body’s immune system, which enables these deadly skin cancers to grow and spread. And while new therapies have been effective in releasing the immune system’s restraints to unleash the body’s own cancer-fighting powers, they only work in...

Kirsch Leads First Trial of Immune Checkpoint Inhibitors For Non-Metastatic Sarcoma

A multi-institutional team of researchers led by Duke Cancer Institute (DCI) radiation oncologist David Kirsch, MD, PhD, has been awarded an eight-year, $2.5 million grant from Stand Up to Cancer . The funds support a clinical trial to investigate the efficacy of treatment of patients with high-...

Ovarian Cancer Screening: Cost Effective?

A group of Duke Cancer Institute gynecologic oncology researchers has published a new paper this month with their projections on the cost-effectiveness of ovarian cancer screening in the U.S., based on their analysis of published results of the UK Collaborative Trial of Ovarian Cancer Screening (...

Lyme Study Uses Drug Discovery Methods That Have Fueled Cancer Breakthroughs

Antibiotics are currently the only treatments available for Lyme disease and other tick-borne illnesses, but researchers at Duke Health are working to expand the medical toolkit by identifying vulnerable areas of the disease-causing bacteria that could lead to innovative therapies. The research...

Pages